export const substanceSymptoms = [
  // Alcohol Use Disorder
  // 12 month period
  {
    label: 'Alcohol is often taken in larger amounts (12 Month Period)',
    value: 1,
  },
  {
    label:
      'Persistent desire or unsuccessful efforts to cut down or control alcohol use (12 Month Period)',
    value: 2,
  },
  {
    label:
      'A great deal of time is spent in activities necessary to obtain alcohol, use alcohol, or recover from its effects (12 Month Period)',
    value: 3,
  },
  {
    label:
      'Craving, or a strong desire or urge to use alcohol (12 Month Period)',
    value: 4,
  },
  {
    label:
      'Recurrent alcohol use resulting in a failure to fulfill major role obligations at work, school, or home (12 Month Period)',
    value: 5,
  },
  {label: 'Continued alcohol use (12 Month Period)', value: 6},
  {
    label:
      'Important social, occupational, or recreational activities are given up or reduced because of alcohol use (12 Month Period)',
    value: 7,
  },
  {
    label:
      'Recurrent alcohol use in situations in which it is physically hazardous (12 Month Period)',
    value: 8,
  },
  {
    label:
      'Alcohol use is continued despite knowledge of having a persistent or recurrent physical or psychological problem (12 Month Period)',
    value: 9,
  },
  {
    label:
      '•Need for markedly increased amounts of alcohol to achieve intoxication or desired effect. \n•Diminished effect with continued use of the same amount of alcohol \n•(12 Month Period)',
    value: 10,
  },
  {label: 'Withdrawal (12 Month Period)', value: 11},

  // Alcohol Intoxication
  // Criteria A
  {label: 'Recent ingestion of alcohol', value: 12},

  // Criteria B
  {
    label:
      'Clinically significant problematic behavioral or psychological changes developed shortly after alcohol ingestion \n•Inappropriate sexual or aggressive behavior \n•Mood lability \n•Impaired judgment',
    value: 13,
  },

  // Criteria C (one or more symptoms)
  {label: 'Slurred speech (During and after alcohol use)', value: 14},
  {label: 'Incoordination (During and after alcohol use)', value: 15},
  {label: 'Unsteady gait (During and after alcohol use)', value: 16},
  {label: 'Nystagmus (During and after alcohol use)', value: 17},
  {
    label: 'Impairment in attention or memory (During and after alcohol use)',
    value: 18,
  },
  {label: '•Stupor \n•Coma \n•(During and after alcohol use)', value: 19},

  // Criteria D
  {
    label:
      'The signs or symptoms are not attributable to another medical condition and are not better explained by another mental disorder, including intoxication with another substance',
    value: 20,
  },

  // Alcohol Withdrawal
  // Criteria A
  {
    label:
      'Cessation of (or reduction in) alcohol use that has been heavy and prolonged',
    value: 21,
  },

  // Criteria B (two or more symptoms)
  // several hours to few days
  {label: 'Autonomic Hyperactivity (Several hours to few days)', value: 22},
  {label: 'Increased hand tremor (Several hours to few days)', value: 23},
  {label: 'Insomia (Several hours to few days)', value: 24},
  {label: 'Nausea / vomiting (Several hours to few days)', value: 25},
  {
    label:
      'Transient visual, tactile, or auditory hallucinations or illusions (Several hours to few days)',
    value: 26,
  },
  {label: 'Psychomotor agitation (Several hours to few days)', value: 27},
  {label: 'Anxiety (Several hours to few days)', value: 28},
  {
    label: 'Generalized tonic-clonic seizures (Several hours to few days)',
    value: 29,
  },

  // Criteria C
  {
    label:
      'The signs or symptoms in Criterion B cause clinically significant distress or impairment in social, occupational, or other important areas of functioning',
    value: 30,
  },
  // Criteria D
  {
    label:
      'The signs or symptoms are not attributable to another medical condition and are not better explained by another mental disorder, including intoxication or withdrawal from another substance',
    value: 31,
  },

  // Caffeine Intoxication
  // Criteria  A
  {label: 'Recent consumption of caffeine', value: 32},

  // Criteria B (Five or more symptoms)
  {label: 'Restlessness', value: 33},
  {label: 'Nervousness', value: 34},
  {label: 'Excitement', value: 35},
  {label: 'Insomnia', value: 36},
  {label: 'Flushed Face', value: 37},
  {label: 'Diuresis', value: 38},
  {label: 'Gastrointestinal disturbance', value: 39},
  {label: 'Muscle Twitching', value: 40},
  {label: 'Rambling flow of thought and speech', value: 41},
  {label: 'Tachycardia or cardiac arrhythmia', value: 42},
  {label: 'Periods of inexhaustibility', value: 43},
  {label: 'Psychomotor agitation', value: 44},

  // Criteria C
  // 30
  // Criteria D
  // 20

  // Caffeine Withdrawal
  // Criteria A
  {label: 'Prolonged daily use of caffeine', value: 45},

  // Criteria B
  // 24 hours after caffeine ingestion
  {label: 'Headache (24 hours after caffeine ingestion)', value: 46},
  {
    label: 'Marked fatigue or drowsiness (24 hours after caffeine ingestion)',
    value: 47,
  },
  {
    label:
      'Dysphoric mood, depressed mood, or irritability (24 hours after caffeine ingestion)',
    value: 48,
  },
  {
    label: 'Difficulty concentrating (24 hours after caffeine ingestion)',
    value: 49,
  },
  {label: 'Flu-like symptoms (24 hours after caffeine ingestion)', value: 50},

  // Criteria C
  // 30
  // Criteria D
  {
    label:
      'The signs or symptoms are not associated with the physiological effects of another medical condition',
    value: 51,
  },

  // Cannabis Use Disorder
  // Criteria A ( Two symptoms)
  {
    label:
      'Cannabis is often taken in larger amounts or over a longer period than was intended',
    value: 52,
  },
  {
    label:
      'There is a persistent desire or unsuccessful efforts to cut down or control cannabis use',
    value: 53,
  },
  {
    label:
      'A great deal of time is spent in activities necessary to obtain cannabis, use cannabis, or recover from its effects',
    value: 54,
  },
  {label: 'Craving, or a strong desire or urge to use cannabis', value: 55},
  {
    label:
      'Recurrent cannabis use resulting in a failure to fulfill major role obligations at work, school, or home',
    value: 56,
  },
  {
    label:
      'Continued cannabis use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of cannabis',
    value: 57,
  },
  {
    label:
      'Important social, occupational, or recreational activities are given up or reduced because of cannabis use',
    value: 58,
  },
  {
    label:
      'Recurrent cannabis use in situations in which it is physically hazardous',
    value: 59,
  },
  {
    label:
      'Cannabis use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by cannabis',
    value: 60,
  },
  {
    label:
      '•A need for markedly increased amounts of cannabis to achieve intoxication or desired effect \n•Markedly diminished effect with continued use of the same amount of cannabis',
    value: 61,
  },
  {
    label:
      '•The characteristic withdrawal syndrome for cannabis \n•Cannabis is taken to relieve or avoid withdrawal symptoms',
    value: 62,
  },

  // Cannabis Intoxication
  // Criteria A:
  {label: 'Recent use of cannabis', value: 63},

  // Criteria B
  {
    label:
      'Clinically significant problematic behavioral or psychological changes developed shortly after cannabis use',
    value: 64,
  },

  // Criteria C
  {label: 'Conjunctival Injection (Developed 2 hours after use)', value: 65},
  {label: 'Increased Appetite (Developed 2 hours after use)', value: 66},
  {label: 'Dry MouthDry Mouth (Developed 2 hours after use)', value: 67},
  {label: 'Tachycardia (Developed 2 hours after use)', value: 68},

  // Criteria D
  // 20

  {label: 'Nystagmus', value: 69},

  // Cannabis Withdrawal
  // Criteria A
  {
    label:
      'Cessation of cannabis use that has been heavy and prolonged (i.e., usually daily or almost daily use over a period of at least a few months)',
    value: 70,
  },

  // Criteria B (three or more symptom)
  {label: '•Irritability \n•Anger \n•Aggression', value: 71},
  {label: '•Nervousness \n•Anxiety', value: 72},
  {label: 'Sleep Difficulty', value: 73},
  {label: 'Decreased appetite or weight loss', value: 74},
  // 33
  {label: 'Depressed Mood', value: 76},
  {
    label:
      'At least one of the following physical symptoms causing significant discomfort: abdominal pain, shakiness/tremors, sweating, fever, chills, or headache.\n',
    value: 77,
  },

  // Phencyclidine Use Disorder
  // Criteria A (Two symptoms)
  {
    label:
      'Phencyclidine is often taken in larger amounts or over a longer period than was intended (12 month period)',
    value: 78,
  },
  {
    label:
      'There is a persistent desire or unsuccessful efforts to cut down or control phencyclidine use (12 month period)',
    value: 79,
  },
  {
    label:
      'A great deal of time is spent in activities necessary to obtain phencyclidine, use the phencyclidine, or recover from its effects (12 month period)',
    value: 80,
  },
  {
    label:
      'Craving, or a strong desire or urge to use phencyclidine (12 month period)',
    value: 81,
  },
  {
    label:
      'Recurrent phencyclidine use resulting in a failure to fulfill major role obligations at work, school, or home (12 month period)',
    value: 82,
  },
  {
    label:
      'Continued phencyclidine use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the phencyclidine (12 month period)',
    value: 83,
  },
  {
    label:
      'Important social, occupational, or recreational activities are given up or reduced because of phencyclidine use (12 month period)',
    value: 84,
  },
  {
    label:
      'Recurrent phencyclidine use in situations in which it is physically hazardous (e.g., driving an automobile or operating a machine when impaired by a phencyclidine (12 month period)',
    value: 85,
  },
  {
    label:
      'Phencyclidine use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the phencyclidine (12 month period)',
    value: 86,
  },
  {
    label:
      '•A need for markedly increased amounts of the phencyclidine to achieve intoxication or desired effect \n•"A markedly diminished effect with continued use of the same amount of the phencyclidine (12 month period)',
    value: 87,
  },

  // Other Hallucinogen Intoxication
  // Criteria A
  {label: 'Recent use of a hallucinogen (other than phencyclidine)', value: 88},

  // Criteria B
  {
    label:
      'Clinically significant problematic behavioral or psychological changes',
    value: 89,
  },

  // Criteria C
  {
    label:
      'Perceptual changes occ that developed during haluccinogen use.urring in a state of full wakefulness and alertness',
    value: 90,
  },

  // Criteria D
  {label: 'Pupillary dilation', value: 91},
  // 63
  {label: 'Sweating', value: 92},
  {label: 'Palpitation', value: 93},
  {label: 'Blurring of vision', value: 94},
  {label: 'Tremors', value: 95},
  {label: 'Incoordination', value: 96},

  // Inhalant Use Disorder
  // Criteria A (two or more symptoms)
  {
    label:
      'The inhalant substance is often taken in larger amounts or over a longer period than was intended',
    value: 97,
  },
  {
    label:
      'There is a persistent desire or unsuccessful efforts to cut down or control use of the inhalant substance',
    value: 98,
  },
  {
    label:
      'A great deal of time is spent in activities necessary to obtain the inhalant substance, use it, or recover from its effects',
    value: 99,
  },
  {
    label: 'Craving, or a strong desire or urge to use the inhalant substance',
    value: 100,
  },
  {
    label:
      'Recurrent use of the inhalant substance resulting in a failure to fulfill major role obligations at work, school, or home',
    value: 101,
  },
  {
    label:
      'Continued use of the inhalant substance despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of its use',
    value: 102,
  },
  {
    label:
      'Important social, occupational, or recreational activities are given up or reduced because of use of the inhalant substance',
    value: 103,
  },
  {
    label:
      'Recurrent use of the inhalant substance in situations in which it is physically hazardous',
    value: 104,
  },
  {
    label:
      'Use of the inhalant substance is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance',
    value: 105,
  },
  {
    label:
      'A need for markedly increased amounts of the inhalant substance to achieve intoxication or desired effect \n•A markedly diminished effect with continued use of the same amount of the inhalant substance',
    value: 106,
  },

  // Inhalant Intoxication
  // Criteria A
  {
    label:
      'Recent intended or unintended short-term, high-dose exposure to inhalant substances, including volatile hydrocarbons such as toluene or gasoline',
    value: 107,
  },

  // Criteria B
  {
    label:
      'Clinically significant problematic behavioral or psychological changes (e.g., belligerence, assaultiveness, apathy, impaired judgment) that developed during, or shortly after, exposure to inhalants',
    value: 108,
  },

  // Criteria C (two or more symptom)
  {label: 'Dizziness (Developed during inhalant use)', value: 109},
  {label: 'Nystagmus (Developed during inhalant use)', value: 110},
  {label: 'Incoordination (Developed during inhalant use)', value: 111},
  {label: 'Slurred Speech (Developed during inhalant use)', value: 112},
  {label: 'Unsteady Gait (Developed during inhalant use)', value: 113},
  {label: 'Lethargy (Developed during inhalant use)', value: 114},
  {label: 'Depressed Reflexes (Developed during inhalant use)', value: 115},
  {
    label: 'Psychomotor retardation (Developed during inhalant use)',
    value: 116,
  },
  {label: 'Tremor (Developed during inhalant use)', value: 117},
  {
    label: 'Generalized muscle weakness (Developed during inhalant use)',
    value: 118,
  },
  {
    label: 'Blurred Vision or Diplopia (Developed during inhalant use)',
    value: 119,
  },
  {label: 'Stupor \n•Coma \n•(Developed during inhalant use)', value: 120},
  {label: 'Euphoria (Developed during inhalant use', value: 121},

  // Criteria D
  // 20

  // Opioid Use Disorder
  // Criteria A (two or more symptoms)
  {
    label:
      'Opioids are often taken in larger amounts or over a longer period than was intended',
    value: 122,
  },
  {
    label:
      'There is a persistent desire or unsuccessful efforts to cut down or control opioid use',
    value: 123,
  },
  {
    label:
      'A great deal of time is spent in activities necessary to obtain the opioid, use the opioid, or recover from its effects',
    value: 124,
  },
  {label: 'Craving, or a strong desire or urge to use opioids', value: 125},
  {
    label:
      'Recurrent opioid use resulting in a failure to fulfill major role obligations at work, school, or home',
    value: 126,
  },
  {
    label:
      'Continued opioid use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of opioids',
    value: 127,
  },
  {
    label:
      'Recurrent opioid use in situations in which it is physically hazardous',
    value: 128,
  },
  {
    label:
      'Continued opioid use despite knowledge of having a persistent or recurrent physical or psychological problem',
    value: 129,
  },
  {
    label:
      '•A need for markedly increased amounts of opioids to achieve intoxication or desired effect \n•A markedly diminished effect with continued use of the same amount of an opioid',
    value: 130,
  },

  // Opioid Intoxication
  // Criteria A
  {label: 'Recent use of an opioid', value: 131},

  // Critera B
  {
    label:
      'Clinically significant problematic behavioral or psychological changes (e.g., initial euphoria followed by apathy, dysphoria, psychomotor agitation or retardation, impaired judgment) that developed during, or shortly after, opioid use',
    value: 132,
  },

  // Criteria C (One or more symptoms')
  {label: 'Drowsiness', value: 133},
  // 160
  {label: 'Impairment in attention or memory', value: 134},

  // Criteria D
  // 20

  // Opioid Withdrawal
  // Criteria A
  {
    label:
      'Cessation of (or reduction in) opioid use that has been heavy and prolonged',
    value: 135,
  },
  {
    label:
      'Administration of an opioid antagonist after a period of opioid use',
    value: 136,
  },

  // Criteria B
  {
    label:
      'Dysphoric Mood (Within minutes to several days after adminiter of opiod)',
    value: 137,
  },
  {
    label:
      'Nausea \n•Vomiting \n•(Within minutes to several days after adminiter of opiod)',
    value: 138,
  },
  {
    label:
      'Muscle aches (Within minutes to several days after adminiter of opiod)',
    value: 139,
  },
  {
    label:
      'Lacrimation (Within minutes to several days after adminiter of opiod)',
    value: 140,
  },
  {
    label:
      'Puppilary Dilation (Within minutes to several days after adminiter of opiod)',
    value: 141,
  },
  {
    label: 'Diarrhea (Within minutes to several days after adminiter of opiod)',
    value: 142,
  },
  {
    label: 'Yawning (Within minutes to several days after adminiter of opiod)',
    value: 143,
  },
  {
    label: 'Fever (Within minutes to several days after adminiter of opiod)',
    value: 144,
  },
  {
    label: 'Insomia (Within minutes to several days after adminiter of opiod)',
    value: 145,
  },

  // Criteria C
  // 30

  // Criteria D
  // 31

  // Sedative, Hypnotic, or Anxiolytic Use Disorder
  // Criteria A
  {
    label:
      'Sedatives, hypnotics, or anxiolytics are often taken in larger amounts or over a longer period than was intended (Within 12 month period)',
    value: 146,
  },
  {
    label:
      'There is a persistent desire or unsuccessful efforts to cut down or control sedative, hypnotic, or anxiolytic use (Within 12 month period)',
    value: 147,
  },
  {
    label:
      'A great deal of time is spent in activities necessary to obtain the sedative, hypnotic, or anxiolytic; use the sedative, hypnotic, or anxiolytic; or recover from its effects (Within 12 month period)',
    value: 148,
  },
  {
    label:
      'Craving, or a strong desire or urge to use the sedative, hypnotic, or anxiolytic (Within 12 month period)',
    value: 149,
  },
  {
    label:
      'Continued sedative, hypnotic, or anxiolytic use despite having persistent or recurrent social or interpersonal problems (Within 12 month period)',
    value: 150,
  },
  {
    label:
      'Important social, occupational, or recreational activities are given up or reduced because of sedative, hypnotic, or anxiolytic use (Within 12 month period)',
    value: 151,
  },
  {
    label:
      'Recurrent sedative, hypnotic, or anxiolytic use in situations in which it is physically hazardous (Within 12 month period)',
    value: 152,
  },
  {
    label:
      'Sedative, hypnotic, or anxiolytic use is continued despite knowledge of having a persistent or recurrent physical or psychological problem (Within 12 month period)',
    value: 152,
  },
  {
    label:
      'Need for markedly increased amounts of the sedative, hypnotic, or anxiolytic to achieve intoxication or desired effect (Within 12 month period)',
    value: 153,
  },
  {
    label:
      'Markedly diminished effect with continued use of the same amount of the sedative, hypnotic, or anxiolytic (Within 12 month period)',
    value: 154,
  },
  {
    label:
      '•Withdrawal syndrome for sedatives, hypnotics, or anxiolytics \n•Sedatives, hypnotics, or anxiolytics are taken to relieve or avoid withdrawal symptoms \n•(Within 12 month period)',
    value: 155,
  },

  // Sedative, Hypnotic, or Anxiolytic Intoxication
  // Criteria A
  {label: 'Recent use of a sedative, hypnotic, or anxiolytic', value: 156},

  // Criteria B
  {
    label:
      'Clinically significant maladaptive behavioral or psychological changes that developed during, or shortly after, sedative, hypnotic, or anxiolytic use',
    value: 157,
  },

  // Criteria C (one or more symptoms)
  {
    label:
      'Slurred Speech (During or after sedative, hypnotic, or anxiolytic use)',
    value: 158,
  },
  {
    label: 'Sweating (During or after sedative, hypnotic, or anxiolytic use)',
    value: 159,
  },
  {
    label:
      'Unsteady gait (During or after sedative, hypnotic, or anxiolytic use)',
    value: 160,
  },
  {
    label: 'Nystagmus (During or after sedative, hypnotic, or anxiolytic use)',
    value: 161,
  },
  {
    label:
      'Impairment in cognition (During or after sedative, hypnotic, or anxiolytic use)',
    value: 162,
  },
  {
    label:
      '•Stupor \n•Coma \n•(During or after sedative, hypnotic, or anxiolytic use)',
    value: 163,
  },

  // Criteria D
  // 20

  // Sedative, Hypnotic, or Anxiolytic Withdrawal
  // Criteria A
  {
    label:
      'Cessation of (or reduction in) sedative, hypnotic, or anxiolytic use that has been prolonged',
    value: 164,
  },

  // Criteria B
  // Several hours to few days after reduction of sedative, hypnotic, or anxiolytic use described
  {
    label:
      'Autonomic Hyperactivity (Several hours to few days after reduction of sedative, hypnotic, or anxiolytic use described)',
    value: 165,
  },
  {
    label:
      'Hand Tremor (Several hours to few days after reduction of sedative, hypnotic, or anxiolytic use described)',
    value: 166,
  },
  {
    label:
      'Insomnia (Several hours to few days after reduction of sedative, hypnotic, or anxiolytic use described)',
    value: 167,
  },
  {
    label:
      '•Nausea \n•Vomiting \n•(Several hours to few days after reduction of sedative, hypnotic, or anxiolytic use described)',
    value: 168,
  },
  {
    label:
      'Transient Visual (Several hours to few days after reduction of sedative, hypnotic, or anxiolytic use described)',
    value: 169,
  },
  {
    label:
      'Psychomotor agitation (Several hours to few days after reduction of sedative, hypnotic, or anxiolytic use described)',
    value: 170,
  },
  {
    label:
      'Anxiety (Several hours to few days after reduction of sedative, hypnotic, or anxiolytic use described)',
    value: 171,
  },
  {
    label:
      'Grand Mal Seizures (Several hours to few days after reduction of sedative, hypnotic, or anxiolytic use described)',
    value: 172,
  },

  // Criteria C
  // 30

  // Criteria D
  // 31

  // Stimulant Use Disorder
  {
    label:
      'The stimulant is often taken in larger amounts or over a longer period than was intended (Within 12 month period)',
    value: 173,
  },
  {
    label:
      'There is a persistent desire or unsuccessful efforts to cut down or control stimulant use (Within 12 month period)',
    value: 174,
  },
  {
    label:
      'A great deal of time is spent in activities necessary to obtain the stimulant, use the stimulant, or recover from its effects (Within 12 month period)',
    value: 175,
  },
  {
    label:
      'Craving, or a strong desire or urge to use the stimulant (Within 12 month period',
    value: 176,
  },
  {
    label:
      'Recurrent stimulant use resulting in a failure to fulfill major role obligations at work, school, or home (Within 12 month period)',
    value: 177,
  },
  {
    label:
      'Continued stimulant use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the stimulant (Within 12 month period)',
    value: 178,
  },
  {
    label:
      'Important social, occupational, or recreational activities are given up or reduced because of stimulant use (Within 12 month period)',
    value: 179,
  },
  {
    label:
      'Recurrent stimulant use in situations in which it is physically hazardous (Within 12 month period)',
    value: 180,
  },
  {
    label:
      'Stimulant use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the stimulant (Within 12 month period)',
    value: 181,
  },
  {
    label:
      '•A need for markedly increased amounts of the stimulant to achieve intoxication or desired effect \n•A markedly diminished effect with continued use of the same amount of the stimulant \n•(Within 12 month period)',
    value: 182,
  },
  {
    label:
      '•The characteristic withdrawal syndrome for stimulant \n•The stimulant  (or a closely related substance) are taken to relieve or avoid withdrawal symptoms \n•(Within 12 month period)',
    value: 183,
  },

  // Stimulant Intoxication
  // Criteria A
  {
    label:
      'Recent use of an amphetamine-type substance, cocaine, or other stimulant',
    value: 184,
  },

  // Critera B
  // 89

  // Criteria C (Two or more symptom)
  {label: 'Tachycardia (Developed during stimulant use)', value: 185},
  {label: 'Puppilary Dilation (Developed during stimulant use)', value: 186},
  {
    label:
      'Elevated or lowered blood pressure (Developed during stimulant use)',
    value: 187,
  },
  {label: 'Perspiration or chill (Developed during stimulant use)', value: 188},
  {
    label: '•Nausea \n•Vomiting \n•(Developed during stimulant use)',
    value: 189,
  },
  {
    label: 'Evidence of weight loss (Developed during stimulant use)',
    value: 190,
  },
  {label: 'Psychomotor agitation (Developed during stimulant use)', value: 191},
  {
    label:
      '•Muscular weakness \n•Respiratory depression \n•Chest pain \n•Cardiac arrhytmias \n•(Developed during stimulant use)',
    value: 192,
  },

  // Criteria D
  // 20

  // Stimulant Withdrawal
  // Criteria A
  {
    label:
      'Cessation of (or reduction in) prolonged amphetamine-type substance, cocaine, or other stimulant use',
    value: 193,
  },

  // Criteria B (Two or more symptoms)
  {label: 'Fatigue (Few hours to several days)', value: 194},
  {label: 'Unpleasant vivid dreams (Few hours to several days)', value: 195},
  {label: '•Insomia \n•Hypersomia \n•(Few hours to several days)', value: 196},
  {label: 'Increased Appetite (Few hours to several days)', value: 197},
  {label: 'Psychomotor retardation (Few hours to several days)', value: 198},

  // Criteria C
  // 30

  // Criteria D
  // 31

  // Tobacco Use Disorder
  {
    label:
      'Tobacco is often taken in larger amounts or over a longer period than was intended (Within 12 months)',
    value: 199,
  },
  {
    label:
      'There is a persistent desire or unsuccessful efforts to cut down or control tobacco use (Within 12 months)',
    value: 200,
  },
  {
    label:
      'A great deal of time is spent in activities necessary to obtain or use tobacco (Within 12 months)',
    value: 201,
  },
  {label: 'Craving, or a strong desire or urge to use tobacco', value: 210},
  {
    label:
      'Recurrent tobacco use resulting in a failure to fulfill major role obligations at work, school, or home (e.g., interference with work) (Within 12 months)',
    value: 202,
  },
  {
    label:
      'Continued tobacco use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of tobacco (Within 12 months)',
    value: 203,
  },
  {
    label:
      'Important social, occupational, or recreational activities are given up or reduced because of tobacco use (Within 12 months)',
    value: 204,
  },
  {label: 'Recurrent tobacco use', value: 205},
  {
    label:
      'Tobacco use is continued despite knowledge of having a persistent or recurrent physical or psychological problem (Within 12 months)',
    value: 206,
  },
  {
    label:
      '•A need for markedly increased amounts of tobacco to achieve the desired effect \n•A markedly diminished effect with continued use of the same amount of tobacco (Within 12 months)',
    value: 207,
  },
  {
    label:
      '•The characteristic withdrawal syndrome for tobacco \n•Tobacco  is taken to relieve or avoid withdrawal symptoms (Within 12 months)',
    value: 208,
  },

  // Tobacco Withdrawal
  // Criteria A
  {label: 'Daily use of tobacco for at least several weeks', value: 209},

  // Criteria B
  {
    label:
      '•Irritability \n•Frustration \n•Anger (24 hours after tobacco reduction)',
    value: 210,
  },
  {
    label: 'Difficulty Concentrating (24 hours after tobacco reduction)',
    value: 211,
  },
  {label: 'Increased Appetite (24 hours after tobacco reduction)', value: 212},
  {label: 'Restlessness (24 hours after tobacco reduction)', value: 213},
  {label: 'Depressed Mood (24 hours after tobacco reduction)', value: 214},
  {label: 'Insomnia (24 hours after tobacco reduction)', value: 215},

  // Criteria C
  // 30

  // Criteria D
  {
    label:
      'The signs or symptoms are not attributed to another medical condition and are not better explained by another mental disorder, including intoxication or withdrawal from another substance',
    value: 216,
  },

  // Other (or Unknown) Substance Use Disorder
  // Criteria A
  {
    label:
      'The substance is often taken in larger amounts or over a longer period than was intended',
    value: 217,
  },
  {
    label:
      'There is a persistent desire or unsuccessful efforts to cut down or control use of the substance',
    value: 218,
  },
  {
    label:
      'A great deal of time is spent in activities necessary to obtain the substance, use the substance, or recover from its effects',
    value: 219,
  },
  {
    label: 'Craving, or a strong desire or urge to use the substance',
    value: 220,
  },
  {
    label:
      'Recurrent use of the substance resulting in a failure to fulfill major role obligations at work, school, or home',
    value: 221,
  },
  {
    label:
      'Continued use of the substance despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of its use',
    value: 222,
  },
  {
    label:
      'Important social, occupational, or recreational activities are given up or reduced because of use of the substance',
    value: 223,
  },
  {
    label:
      'Recurrent use of the substance in situations in which it is physically hazardous',
    value: 224,
  },
  {
    label:
      'Use of the substance is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance',
    value: 225,
  },
  {
    label:
      '•A need for markedly increased amounts of the substance to achieve intoxication or desired effect \n•A markedly diminished effect with continued use of the same amount of the substance',
    value: 226,
  },
  {
    label:
      '•The characteristic withdrawal syndrome for other substance withdrawal) \n•The substance (or a closely related substance) is taken to relieve or avoid withdrawal symptoms',
    value: 227,
  },

  // Other (or Unknown) Substance Withdrawal
  // Criteria A
  {
    label:
      'Cessation of (or reduction in) use of a substance that has been heavy and prolonged',
    value: 228,
  },

  // Criteria B
  {
    label:
      'The development of a substance-specific syndrome shortly after the cessation of (or reduction in) substance use',
    value: 229,
  },

  // Criteria C
  {
    label:
      'The substance-specific syndrome causes clinically significant distress or impairment in social, occupational, or other important areas of functioning',
    value: 230,
  },

  // Criteria D
  {
    label:
      'The symptoms are not attributable to another medical condition and are not better explained by another mental disorder, including withdrawal from another substance',
    value: 231,
  },

  // Criteria E
  {
    label:
      'The substance involved cannot be classified under any of the other substance categories (alcohol; caffeine; cannabis; opioids; sedatives, hypnotics, or anxiolytics; stimulants; or tobacco) or is unknown',
    value: 232,
  },

  // Gambling Disorder
  // Criteria A (Four or more symptoms)
  {
    label:
      'Needs to gamble with increasing amounts of money in order to achieve the desired excitement (12 month period)',
    value: 233,
  },
  {
    label:
      'Is restless or irritable when attempting to cut down or stop gambling (12 month period)',
    value: 234,
  },
  {
    label:
      'Has made repeated unsuccessful efforts to control, cut back, or stop gambling (12 month period)',
    value: 235,
  },
  {label: 'Is often preoccupied with gambling (12 month period)', value: 236},
  {
    label: 'Often gambles when feeling distressed (12 month period)',
    value: 237,
  },
  {
    label:
      'After losing money gambling, often returns another day to get even (12 month period)',
    value: 238,
  },
  {
    label:
      'Lies to conceal the extent of involvement with gambling (12 month period)',
    value: 239,
  },
  {
    label:
      'Has jeopardized or lost a significant relationship, job, or educational or career opportunity because of gambling (12 month period)',
    value: 240,
  },
  {
    label:
      'Relies on others to provide money to relieve desperate financial situations caused by gambling (12 month period)',
    value: 241,
  },
  {
    label: 'The gambling behavior is not better explained by a manic episode',
    value: 242,
  },

  // Unspecified Alcohol-Related Disorder
  {
    label:
      'Alcohol-related disorder that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning predominate but do not meet the full criteria for any specific alcohol-related disorder or any of the disorders in the substance-related and addictive disorders diagnostic class',
    value: 252,
  },

  // Unspecified Caffeine-Related Disorder
  {
    label:
      'Caffeine-related disorder that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning predominate but do not meet the full criteria for any specific caffeine-related disorder or any of the disorders in the substance-related and addictive disorders diagnostic class',
    value: 253,
  },

  // Unspecified Cannabis-Related Disorder
  {
    label:
      'This category applies to presentations in which symptoms characteristic of a cannabis-related disorder that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning predominate but do not meet the full criteria for any specific cannabis related disorder or any of the disorders in the substance-related and addictive disorders diagnostic class',
    value: 254,
  },

  // Unspecified Phencyclidine-Related Disorder
  {
    label:
      'This category applies to presentations in which symptoms characteristic of a phencyclidine-related disorder that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning predominate but do not meet the full criteria for any specific phencyclidine-related disorder or any of the disorders in the substance-related and addictive disorders diagnostic class',
    value: 255,
  },

  // Unspecified Hallucinogen-Related Disorder
  {
    label:
      'This category applies to presentations in which symptoms characteristic of a hallucinogen-related disorder that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning predominate but do not meet the full criteria for any specific hallucinogen-related disorder or any of the disorders in the substance-related and addictive disorders diagnostic class',
    value: 256,
  },

  // Unspecified Inhalant-Related Disorder
  {
    label:
      'This category applies to presentations in which symptoms characteristic of an inhalant-related disorder that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning predominate but do not meet the full criteria for any specific inhalant-related disorder or any of the disorders in the substance-related and addictive disorders diagnostic class',
    value: 257,
  },

  // Unspecified Opioid-Related Disorder
  {
    label:
      'This category applies to presentations in which symptoms characteristic of an opioid-related disorder that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning predominate but do not meet the full criteria for any specific opioid-related disorder or any of the disorders in the substance-related and addictive disorders diagnostic class',
    value: 258,
  },

  // Unspecified Sedative-, Hypnotic-, or Anxiolytic-Related Disorder
  {
    label:
      'This category applies to presentations in which symptoms characteristic of a sedative-, hypnotic-, or anxiolytic-related disorder that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning predominate but do not meet the full criteria for any specific sedative-, hypnotic-, or anxiolytic-related disorder or any of the disorders in the substance-related and addictive disorders diagnostic class',
    value: 259,
  },

  // Unspecified Tobacco-Related Disorder
  {
    label:
      'This category applies to presentations in which symptoms characteristic of a tobacco-related disorder that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning predominate but do not meet the full criteria for any specific tobacco-related disorder or any of the disorders in the substance-related and addictive disorders diagnostic class',
    value: 260,
  },

  // Unspecified Stimulant-Related Disorder
  {
    label:
      'This category applies to presentations in which symptoms characteristic of a stimulant-related disorder that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning predominate but do not meet the full criteria for any specific stimulant-related disorder or any of the disorders in the substance-related and addictive disorders diagnostic class',
    value: 261,
  },
];

export const mainDisorderA = numbers => {
  const criteriaValues = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return matchingCriteria.length >= 2;
};

export const optionalDisorderB = numbers => {
  const criteriaValues = [14, 15, 16, 17, 18, 19];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return (
    numbers.includes(12) || matchingCriteria.length >= 1 || numbers.includes(20)
  );
};

export const mainDisorderC = numbers => {
  const criteriaValues = [22, 23, 24, 25, 26, 27, 28, 29];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return numbers.includes(21) && matchingCriteria.length >= 2;
};

export const optionalDisorderC = numbers => {
  return numbers.includes(30) || numbers.includes(20);
};

export const mainDisorderD = numbers => {
  const criteriaValues = [33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return numbers.includes(32) && matchingCriteria.length >= 2;
};

export const mainDisorderE = numbers => {
  const criteriaValues = [46, 47, 48, 49, 50];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return matchingCriteria.length >= 3;
};

export const optionalDisorderE = numbers => {
  return numbers.includes(45) || numbers.includes(30) || numbers.includes(51);
};

export const mainDisorderF = numbers => {
  const criteriaValues = [52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return matchingCriteria.length >= 2;
};

export const mainDisorderG = numbers => {
  return numbers.includes(64);
};

export const optionalDisorderG = numbers => {
  const criteriaValues = [65, 66, 67, 68];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return (
    numbers.includes(63) || matchingCriteria.length >= 2 || numbers.includes(69)
  );
};

export const mainDisorderH = numbers => {
  const criteriaValues = [71, 72, 73, 74, 33, 76, 77];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return numbers.includes(70) && matchingCriteria.length >= 3;
};

export const optionalDisorderH = numbers => {
  return numbers.includes(30) || numbers.includes(31);
};

export const mainDisorderI = numbers => {
  const criteriaValues = [78, 79, 80, 81, 82, 83, 84, 85, 86, 87];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return matchingCriteria.length >= 2;
};

export const mainDisorderJ = numbers => {
  return numbers.includes(88) && numbers.includes(89) && numbers.includes(90);
};

export const optionalDisorderJ = numbers => {
  const criteriaValues = [91, 63, 92, 93, 94, 95, 96];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return matchingCriteria.length >= 2 || numbers.includes(20);
};

export const mainDisorderK = numbers => {
  const criteriaValues = [97, 98, 99, 100, 101, 102, 103, 104, 105, 106];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return matchingCriteria.length >= 2;
};

export const mainDisorderL = numbers => {
  return numbers.includes(107) && numbers.includes(108);
};

export const optionalDisorderL = numbers => {
  const criteriaValues = [
    109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121,
  ];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return matchingCriteria.length >= 2 || numbers.includes(20);
};

export const mainDisorderM = numbers => {
  const criteriaValues = [123, 124, 125, 126, 127, 128, 129, 130];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return matchingCriteria.length >= 2;
};

export const mainDisorderN = numbers => {
  return numbers.includes(131) && numbers.includes(132);
};

export const optionalDisorderN = numbers => {
  const criteriaValues = [133, 160, 134];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return matchingCriteria.length >= 1 || numbers.includes(20);
};

export const mainDisorderO = numbers => {
  return numbers.includes(135) && numbers.includes(136);
};

export const optionalDisorderO = numbers => {
  const criteriaValues = [137, 138, 139, 140, 141, 142, 143, 144, 145];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return (
    matchingCriteria.length >= 3 || numbers.includes(30) || numbers.includes(31)
  );
};

export const mainDisorderP = numbers => {
  const criteriaValues = [146, 147, 148, 149, 150, 151, 152, 153, 154, 155];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return matchingCriteria.length >= 3;
};

export const mainDisorderQ = numbers => {
  return numbers.includes(156) && numbers.includes(157);
};

export const optionalDisorderQ = numbers => {
  const criteriaValues = [158, 159, 160, 161, 162, 163];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return matchingCriteria.length >= 1 || numbers.includes(20);
};

export const mainDisorderR = numbers => {
  const criteriaValues = [165, 166, 167, 168, 169, 170, 171, 172];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return matchingCriteria.length >= 2 && numbers.includes(164);
};

export const optionalDisorderR = numbers => {
  return numbers.includes(30) || numbers.includes(31);
};

export const mainDisorderS = numbers => {
  const criteriaValues = [
    173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183,
  ];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return matchingCriteria.length >= 2;
};

export const mainDisorderT = numbers => {
  return numbers.includes(184) && numbers.includes(89);
};

export const optionalDisorderT = numbers => {
  const criteriaValues = [185, 186, 187, 188, 189, 190, 191, 192];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return matchingCriteria.length >= 2 || numbers.includes(20);
};

export const mainDisorderU = numbers => {
  return numbers.includes(193);
};

export const optionalDisorderU = numbers => {
  const criteriaValues = [194, 195, 196, 197, 198];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return (
    matchingCriteria.length >= 2 || numbers.includes(30) || numbers.includes(31)
  );
};

export const mainDisorderV = numbers => {
  const criteriaValues = [199, 200, 201, 202, 203, 204, 205, 206, 207, 208];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return matchingCriteria.length >= 2;
};

export const mainDisorderW = numbers => {
  const criteriaValues = [210, 211, 212, 213, 214, 215];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return matchingCriteria.length >= 2 && numbers.includes(209);
};

export const optionalDisorderW = numbers => {
  return numbers.includes(30) && numbers.includes(216);
};

export const mainDisorderX = numbers => {
  const criteriaValues = [
    217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227,
  ];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return matchingCriteria.length >= 11;
};

export const mainDisorderY = numbers => {
  return numbers.includes(228) && numbers.includes(229);
};

export const optionalDisorderY = numbers => {
  return (
    numbers.includes(230) || numbers.includes(231) || numbers.includes(232)
  );
};

export const mainDisorderZ = numbers => {
  const criteriaValues = [233, 234, 235, 236, 237, 238, 239, 240, 241];
  const matchingCriteria = criteriaValues.filter(value =>
    numbers.includes(value),
  );
  return matchingCriteria.length >= 4;
};

export const substanceDiagnosis = numbers => {
  if (mainDisorderA(numbers)) {
    return 'Alcohol Use Disorder';
  } else if (numbers.includes(13) || optionalDisorderB(numbers)) {
    return 'Alcohol Intoxication';
  } else if (mainDisorderC(numbers) || optionalDisorderC(numbers)) {
    return 'Alcohol Withdrawal';
  } else if (mainDisorderD(numbers) || optionalDisorderC(numbers)) {
    return 'Caffeine Intoxication';
  } else if (mainDisorderE(numbers) || optionalDisorderE(numbers)) {
    return 'Caffeine Withdrawal';
  } else if (mainDisorderF(numbers)) {
    return 'Cannabis Use Disorder';
  } else if (mainDisorderG(numbers) || optionalDisorderG(numbers)) {
    return 'Cannabis Intoxication';
  } else if (mainDisorderH(numbers) || optionalDisorderH(numbers)) {
    return 'Cannabis Withdrawal';
  } else if (mainDisorderI(numbers)) {
    return 'Phencyclidine Use Disorder';
  } else if (mainDisorderJ(numbers) || optionalDisorderJ(numbers)) {
    return 'Other Hallucinogen Intoxication';
  } else if (mainDisorderK(numbers)) {
    return 'Inhalant Use Disorder';
  } else if (mainDisorderL(numbers) || optionalDisorderL(numbers)) {
    return 'Inhalant Intoxication';
  } else if (mainDisorderM(numbers)) {
    return 'Opioid Use Disorder';
  } else if (mainDisorderN(numbers) || optionalDisorderN(numbers)) {
    return 'Opioid Intoxication';
  } else if (mainDisorderO(numbers) || optionalDisorderO(numbers)) {
    return 'Opioid Withdrawal';
  } else if (mainDisorderP(numbers)) {
    return 'Sedative, Hypnotic, or Anxiolytic Use Disorder';
  } else if (mainDisorderQ(numbers) || optionalDisorderQ(numbers)) {
    return 'Sedative, Hypnotic, or Anxiolytic Intoxication';
  } else if (mainDisorderR(numbers) || optionalDisorderR(numbers)) {
    return 'Sedative, Hypnotic, or Anxiolytic Withdrawal';
  } else if (mainDisorderS(numbers)) {
    return 'Stimulant Use Disorder';
  } else if (mainDisorderT(numbers) || optionalDisorderT(numbers)) {
    return 'Stimulant Intoxication';
  } else if (mainDisorderU(numbers) || optionalDisorderU(numbers)) {
    return 'Stimulant Withdrawal';
  } else if (mainDisorderV(numbers)) {
    return 'Tobacco Use Disorder';
  } else if (mainDisorderW(numbers) || optionalDisorderW(optionalDisorderW)) {
    return 'Tobacco Withdrawal';
  } else if (mainDisorderX(numbers)) {
    return 'Other (or Unknown) Substance Use Disorder';
  } else if (mainDisorderY(numbers) || optionalDisorderY(numbers)) {
    return 'Other (or Unknown) Substance Withdrawal';
  } else if (mainDisorderZ(numbers) || numbers.includes(242)) {
    return 'Gambling Disorder';
  } else if (numbers.includes(252)) {
    return 'Unspecified Alcohol-Related Disorder';
  } else if (numbers.includes(253)) {
    return 'Unspecified Caffeine-Related Disorder';
  } else if (numbers.includes(254)) {
    return 'Unspecified Cannabis-Related Disorder';
  } else if (numbers.includes(255)) {
    return 'Unspecified Phencyclidine-Related Disorder';
  } else if (numbers.includes(256)) {
    return 'Unspecified Hallucinogen-Related Disorder';
  } else if (numbers.includes(257)) {
    return 'Unspecified Inhalant-Related Disorder';
  } else if (numbers.includes(258)) {
    return 'Unspecified Opioid-Related Disorder';
  } else if (numbers.includes(259)) {
    return 'Unspecified Sedative-, Hypnotic-, or Anxiolytic-Related Disorder';
  } else if (numbers.includes(260)) {
    return 'Unspecified Stimulant-Related Disorder';
  } else if (numbers.includes(261)) {
    return 'Unspecified Tobacco-Related Disorder';
  } else {
    return 'Unspecified Other (or Unknown) Substance– Related Disorder';
  }
};

export const alcoholUseDuration = [
  {
    label:
      'After full criteria for alcohol use disorder were previously met, none of the criteria for alcohol use disorder have been met for at least 3 months but for less than 12 months',
    value: 31,
  },
  {
    label:
      'After full criteria for alcohol use disorder were previously met, none of the criteria for alcohol use disorder have been met at any time during a period of 12 months or longer',
    value: 32,
  },
  {
    label:
      'This additional specifier is used if the individual is in an environment where access to alcohol is restricted',
    value: 22,
  },
];

export const alcoholUseSeverity = [
  {
    label: 'Presence of 2–3 symptoms',
    value: 86,
  },
  {
    label: '(Mild) •In early remission \n•In sustained remission',
    value: 87,
  },
  {
    label: 'Presence of 4–5 symptoms',
    value: 88,
  },
  {
    label: '(Moderate) •In early remission \n•In sustained remission',
    value: 89,
  },
  {
    label: 'Presence of 6 or more symptoms',
    value: 90,
  },
  {
    label: '(Severe) •In early remission \n•In sustained remission',
    value: 91,
  },
];

export const alcoholWithdrawalSpecification = [
  {
    label:
      'This specifier applies in the rare instance when hallucinations (usually visual or tactile) occur with intact reality testing, or auditory, visual, or tactile illusions occur in the absence of a delirium',
    value: 62,
  },
];

export const alcoholWithdrawalSeverity = [
  {
    label: '(Without perceptual disturbances) Mild alcohol use disorder',
    value: 93,
  },
  {
    label:
      '(Without perceptual disturbances) Moderate or Severe alcohol use disorder',
    value: 94,
  },
  {
    label: '(Without perceptual disturbances) No comorbid alcohol use disorder',
    value: 95,
  },
  {
    label: '(With perceptual disturbances) Mild alcohol use disorder',
    value: 96,
  },
  {
    label:
      '(With perceptual disturbances) Moderate or Severe alcohol use disorder',
    value: 97,
  },
  {
    label: '(With perceptual disturbances) No comorbid alcohol use disorder',
    value: 98,
  },
];

export const cannabisUseDuration = [
  {
    label:
      'After full criteria for cannabis use disorder were previously met, none of the criteria for cannabis use disorder have been met for at least 3 months but for less than 12 months',
    value: 31,
  },
  {
    label:
      'After full criteria for cannabis use disorder were previously met, none of the criteria for cannabis use disorder have been met at any time during a period of 12 months or longer',
    value: 32,
  },
  {
    label:
      'This additional specifier is used if the individual is in an environment where access to cannabis is restricted',
    value: 22,
  },
];

export const cannabisUseSeverity = [
  {
    label: 'Presence of 2–3 symptoms',
    value: 99,
  },
  {
    label: '(Mild)•In early remission \n•In sustained remission',
    value: 100,
  },
  {
    label: 'Presence of 4–5 symptoms',
    value: 101,
  },
  {
    label: '(Moderate) •In early remission \n•In sustained remission',
    value: 102,
  },
  {
    label: 'Presence of 6 or more symptoms',
    value: 103,
  },
  {
    label: '(Severe) •In early remission \n•In sustained remission',
    value: 104,
  },
];

export const cannabisIntoxicationSeverity = [
  {
    label: '(Without perceptual disturbances) Mild cannabis use disorder',
    value: 105,
  },
  {
    label:
      '(Without perceptual disturbances) Moderate or Severe cannabis use disorder',
    value: 106,
  },
  {
    label:
      '(Without perceptual disturbances) No comorbid cannabis use disorder',
    value: 107,
  },
  {
    label: '(With perceptual disturbances) Mild cannabis use disorder',
    value: 108,
  },
  {
    label:
      '(With perceptual disturbances) Moderate or Severe cannabis use disorder',
    value: 109,
  },
  {
    label: '(With perceptual disturbances) No comorbid cannabis use disorder',
    value: 110,
  },
];

export const phencyclidineUseDuration = [
  {
    label:
      'After full criteria for phencyclidine use disorder were previously met, none of the criteria for phencyclidine use disorder have been met for at least 3 months but for less than 12 months',
    value: 31,
  },
  {
    label:
      'After full criteria for phencyclidine use disorder were previously met, none of the criteria for phencyclidine use disorder have been met at any time during a period of 12 months or longer',
    value: 32,
  },
  {
    label:
      'This additional specifier is used if the individual is in an environment where access to phencyclidine is restricted',
    value: 22,
  },
];

export const phencyclidineUseSeverity = [
  {
    label: 'Presence of 2–3 symptoms',
    value: 111,
  },
  {
    label: '(Mild) •In early remission \n•In sustained remission',
    value: 112,
  },
  {
    label: 'Presence of 4–5 symptoms',
    value: 113,
  },
  {
    label: '(Moderate) •In early remission \n•In sustained remission',
    value: 114,
  },
  {
    label: 'Presence of 6 or more symptoms',
    value: 115,
  },
  {
    label: '(Severe) •In early remission \n•In sustained remission',
    value: 116,
  },
];

export const hallucinogenSeverity = [
  {
    label: 'Mild hallucinogen use disorder',
    value: 117,
  },
  {
    label: 'Moderate or Severe hallucinogen use disorder',
    value: 118,
  },
  {
    label: 'No comorbid hallucinogen use disorder',
    value: 119,
  },
];

export const inhalantUseDuration = [
  {
    label:
      'After full criteria for inhalant use disorder were previously met, none of the criteria for inhalant use disorder have been met for at least 3 months but for less than 12 months',
    value: 31,
  },
  {
    label:
      'After full criteria for inhalant use disorder were previously met, none of the criteria for inhalant use disorder have been met at any time during a period of 12 months or longer',
    value: 32,
  },
  {
    label:
      'This additional specifier is used if the individual is in an environment where access to inhalant is restricted',
    value: 22,
  },
];

export const inhalantUseSeverity = [
  {
    label: 'Presence of 2–3 symptoms',
    value: 120,
  },
  {
    label: '(Mild) •In early remission \n•In sustained remission',
    value: 121,
  },
  {
    label: 'Presence of 4–5 symptoms',
    value: 122,
  },
  {
    label: '(Moderate) •In early remission \n•In sustained remission',
    value: 123,
  },
  {
    label: 'Presence of 6 or more symptoms',
    value: 124,
  },
  {
    label: '(Severe) •In early remission \n•In sustained remission',
    value: 125,
  },
];

export const opioidUseSeverity = [
  {
    label: 'Presence of 2–3 symptoms',
    value: 126,
  },
  {
    label: '(Mild) •In early remission \n•In sustained remission',
    value: 127,
  },
  {
    label: 'Presence of 4–5 symptoms',
    value: 128,
  },
  {
    label: '(Moderate) •In early remission \n•In sustained remission',
    value: 129,
  },
  {
    label: 'Presence of 6 or more symptoms',
    value: 130,
  },
  {
    label: '(Severe) •In early remission \n•In sustained remission',
    value: 131,
  },
];

export const opioidIntoxicationSeverity = [
  {
    label: '(Without perceptual disturbances) Mild opioid use disorder',
    value: 132,
  },
  {
    label:
      '(Without perceptual disturbances) Moderate or Severe opioid use disorder',
    value: 133,
  },
  {
    label: '(Without perceptual disturbances) No comorbid opioid use disorder',
    value: 134,
  },
  {
    label: '(With perceptual disturbances) Mild opioid use disorder',
    value: 135,
  },
  {
    label:
      '(With perceptual disturbances) Moderate or Severe opioid use disorder',
    value: 136,
  },
  {
    label: '(With perceptual disturbances) No comorbid opioid use disorder',
    value: 137,
  },
];

export const sedativeUseDuration = [
  {
    label:
      'After full criteria for sedative use disorder were previously met, none of the criteria for sedative use disorder have been met for at least 3 months but for less than 12 months',
    value: 31,
  },
  {
    label:
      'After full criteria for sedative use disorder were previously met, none of the criteria for sedative use disorder have been met at any time during a period of 12 months or longer',
    value: 32,
  },
  {
    label:
      'This additional specifier is used if the individual is in an environment where access to sedative is restricted',
    value: 22,
  },
];

export const sedativeUseSeverity = [
  {
    label: 'Presence of 2–3 symptoms',
    value: 138,
  },
  {
    label: '(Mild) •In early remission \n•In sustained remission',
    value: 139,
  },
  {
    label: 'Presence of 4–5 symptoms',
    value: 140,
  },
  {
    label: '(Moderate) •In early remission \n•In sustained remission',
    value: 141,
  },
  {
    label: 'Presence of 6 or more symptoms',
    value: 142,
  },
  {
    label: '(Severe) •In early remission \n•In sustained remission',
    value: 143,
  },
];

export const sedativeSeverity = [
  {
    label: 'Mild sedative, hypnotic, or anxiolytic use disorder',
    value: 144,
  },
  {
    label: 'Moderate or Severe sedative, hypnotic, or anxiolytic use disorder',
    value: 145,
  },
  {
    label: 'No comorbid sedative, hypnotic, or anxiolytic use disorder',
    value: 146,
  },
];

export const sedativeWithdrawalSpecification = [
  {
    label:
      'This specifier applies in the rare instance when hallucinations (usually visual or tactile) occur with intact reality testing, or auditory, visual, or tactile illusions occur in the absence of a delirium',
    value: 62,
  },
];

export const sedativeWithdrawalSeverity = [
  {
    label:
      '(Without perceptual disturbances) Mild sedative, hypnotic, or anxiolytic use disorder',
    value: 147,
  },
  {
    label:
      '(Without perceptual disturbances) Moderate or Severe sedative, hypnotic, or anxiolytic use disorder',
    value: 148,
  },
  {
    label:
      '(Without perceptual disturbances) No comorbid sedative, hypnotic, or anxiolytic use disorder',
    value: 149,
  },
  {
    label:
      '(With perceptual disturbances) Mild sedative, hypnotic, or anxiolytic use disorder',
    value: 150,
  },
  {
    label:
      '(With perceptual disturbances) Moderate or Severe sedative, hypnotic, or anxiolytic use disorder',
    value: 151,
  },
  {
    label:
      '(With perceptual disturbances) No comorbid sedative, hypnotic, or anxiolytic use disorder',
    value: 152,
  },
];

export const stimulantUseDuration = [
  {
    label:
      'After full criteria for stimulant use disorder were previously met, none of the criteria for stimulant use disorder have been met for at least 3 months but for less than 12 months',
    value: 31,
  },
  {
    label:
      'After full criteria for stimulant use disorder were previously met, none of the criteria for stimulant use disorder have been met at any time during a period of 12 months or longer',
    value: 32,
  },
  {
    label:
      'This additional specifier is used if the individual is in an environment where access to stimulant is restricted',
    value: 22,
  },
];

export const stimulantUseSeverity = [
  {
    label: 'Mild (Cocaine)',
    value: 153,
  },
  {
    label: 'Mild (Amphetamine-type substance / Other or unspecified stimulant)',
    value: 154,
  },
  {
    label: 'Mild, Early / Sustained Remission (Cocaine)',
    value: 155,
  },
  {
    label:
      'Mild, Early / Sustained Remission (Amphetamine-type substance / Other or unspecified stimulant)',
    value: 156,
  },
  {
    label: 'Moderate (Cocaine)',
    value: 157,
  },
  {
    label:
      'Moderate (Amphetamine-type substance / Other or unspecified stimulant)',
    value: 158,
  },
  {
    label: 'Moderate, Early Remission (Cocaine)',
    value: 159,
  },
  {
    label:
      'Moderate, Early Remission (Amphetamine-type substance / Other or unspecified stimulant)',
    value: 160,
  },
  {
    label: 'Severe (Cocaine)',
    value: 157,
  },
  {
    label:
      'Severe (Amphetamine-type substance / Other or unspecified stimulant)',
    value: 158,
  },
  {
    label: 'Severe, Early Remission (Cocaine)',
    value: 159,
  },
  {
    label:
      'Severe, Early Remission (Amphetamine-type substance / Other or unspecified stimulant)',
    value: 160,
  },
];

export const stimulantIntoxicationSpecification = [
  {
    label:
      'This specifier applies in the rare instance when hallucinations (usually visual or tactile) occur with intact reality testing, or auditory, visual, or tactile illusions occur in the absence of a delirium',
    value: 62,
  },
];

export const stimulantIntoxicationSeverity = [
  {
    label:
      '(Without perceptual disturbances) Mild amphetamine-type substance or other stimulant use disorder',
    value: 161,
  },
  {
    label:
      '(Without perceptual disturbances) Moderate or Severe amphetamine-type substance or other stimulant use disorder',
    value: 162,
  },
  {
    label:
      '(Without perceptual disturbances) No comorbid mild amphetamine-type substance or other stimulant use disorder',
    value: 163,
  },
  {
    label:
      '(Without perceptual disturbances) Moderate or severe cocaine use disorder is comorbid',
    value: 164,
  },
  {
    label: '(Without perceptual disturbances) No comorbid cocaine use disorder',
    value: 165,
  },
  {
    label:
      '(Without perceptual disturbances) Mild cocaine use disorder is comorbid',
    value: 166,
  },
  {
    label:
      '(With perceptual disturbances) Mild amphetamine-type substance or other stimulant use disorder',
    value: 167,
  },
  {
    label:
      '(With perceptual disturbances) Moderate or Severe amphetamine-type substance or other stimulant use disorder',
    value: 168,
  },
  {
    label:
      '(With perceptual disturbances) No comorbid mild amphetamine-type substance or other stimulant use disorder',
    value: 169,
  },
  {
    label:
      '(With perceptual disturbances) Moderate or severe cocaine use disorder is comorbid',
    value: 170,
  },
  {
    label: '(With perceptual disturbances) No comorbid cocaine use disorder',
    value: 171,
  },
  {
    label:
      '(With perceptual disturbances) Mild cocaine use disorder is comorbid',
    value: 172,
  },
];

export const tobaccoUseDuration = [
  {
    label:
      'After full criteria for tobacco use disorder were previously met, none of the criteria for tobacco use disorder have been met for at least 3 months but for less than 12 months',
    value: 31,
  },
  {
    label:
      'After full criteria for tobacco use disorder were previously met, none of the criteria for tobacco use disorder have been met at any time during a period of 12 months or longer',
    value: 32,
  },
  {
    label:
      'This additional specifier is used if the individual is in an environment where access to tobacco is restricted',
    value: 22,
  },
];

export const tobaccoUseSpecification = [
  {
    label:
      'The individual is taking a long-term maintenance medication, such as nicotine replacement medication, and no criteria for tobacco use disorder have been met for that class of medication',
    value: 63,
  },
  {
    label:
      'This additional specifier is used if the individual is in an environment where access to tobacco is restricted',
    value: 64,
  },
];

export const tobaccoUseSeverity = [
  {
    label: 'Presence of 4–5 symptoms',
    value: 173,
  },
  {
    label: '(Moderate) •In early remission \n•In sustained remission',
    value: 174,
  },
  {
    label: 'Presence of 6 or more symptoms',
    value: 173,
  },
  {
    label: '(Severe) •In early remission \n•In sustained remission',
    value: 174,
  },
];

export const otherUnknownUseDuration = [
  {
    label:
      'After full criteria for other or unknown substance use disorder were previously met, none of the criteria for other or unknown substance use disorder have been met for at least 3 months but for less than 12 months',
    value: 31,
  },
  {
    label:
      'After full criteria for other or unknown substance use disorder were previously met, none of the criteria for other or unknown substance use disorder have been met at any time during a period of 12 months or longer',
    value: 32,
  },
  {
    label:
      'This additional specifier is used if the individual is in an environment where access to other or unknown substance is restricted',
    value: 22,
  },
];

export const otherUnknownUseSeverity = [
  {
    label: 'Presence of 2–3 symptoms',
    value: 175,
  },
  {
    label: '(Mild) •In early remission \n•In sustained remission',
    value: 176,
  },
  {
    label: 'Presence of 4–5 symptoms',
    value: 177,
  },
  {
    label: '(Moderate) •In early remission \n•In sustained remission',
    value: 178,
  },
  {
    label: 'Presence of 6 or more symptoms',
    value: 179,
  },
  {
    label: '(Severe) •In early remission \n•In sustained remission',
    value: 180,
  },
];

export const otherUnknownSeverity = [
  {
    label:
      '(Without perceptual disturbances) Mild other or unknown substance use disorder',
    value: 181,
  },
  {
    label:
      '(Without perceptual disturbances) Moderate or Severe other or unknown substance use disorder',
    value: 182,
  },
  {
    label:
      '(Without perceptual disturbances) No comorbid other or unknown substance use disorder',
    value: 183,
  },
  {
    label:
      '(With perceptual disturbances) Mild other or unknown substance use disorder',
    value: 184,
  },
  {
    label:
      '(With perceptual disturbances) Moderate or Severe other or unknown substance use disorder',
    value: 185,
  },
  {
    label:
      '(With perceptual disturbances) No comorbid other or unknown substance use disorder',
    value: 186,
  },
];

export const gamblingDuration = [
  {
    label:
      'Meeting diagnostic criteria at more than one time point, with symptoms subsiding between periods of gambling disorder for at least several month',
    value: 8,
  },
  {
    label:
      'Experiencing continuous symptoms, to meet diagnostic criteria for multiple years',
    value: 1,
  },
  {
    label:
      'After full criteria for gambling disorder were previously met, none of the criteria for gambling use disorder have been met for at least 3 months but for less than 12 months',
    value: 31,
  },
  {
    label:
      'After full criteria for gambling disorder were previously met, none of the criteria for gambling have been met at any time during a period of 12 months or longer',
    value: 32,
  },
];

export const gamblingSeverity = [
  {
    label: '4–5 criteria met',
    value: 4,
  },
  {
    label: '6-7 criteria met',
    value: 5,
  },
  {
    label: '8-9 criteria met',
    value: 6,
  },
];
